Sexually Transmitted Diseases (STDs) Drug Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2
Researchmoz added Most up-to-date research on "Sexually Transmitted Diseases (STDs) Drug Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" to its huge collection of research reports.
Global Sexually Transmitted Diseases (STDs) Drugs: Overview
Sexually transmitted diseases (STDs), also referred as venereal diseases are infections that can pass from person to person during sex. These diseases are caused mainly due to bacteria, viruses, and / or parasites. Sexually transmitted diseases (STDs) often go undiagnosed because these infections usually do not exhibit visual symptoms. Chlamydia is a common sexually transmitted disease. It is caused by bacteria called Chlamydia trachomatis. It can infect both men and women. Gonorrhea is caused due to bacterial infection (bacterium Neisseria gonorrhoeae) that can be passed from one person to another during sex. The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss of ability to fight against the organism that causes disease.
Global Sexually Transmitted Diseases (STDs) Drugs: Trends and Opportunities
The global market for sexually transmitted diseases (STDs) drug is expanding significantly, owing to increased chances of infection led by increase in the life expectancy of people across the globe. Rise in incidences of unprotected sex has led to an increase in the prevalence of sexually transmitted diseases. A driving factor for the sexually transmitted diseases (STDs) drug is rising initiatives by governments and multiple agencies drawn up guidelines or recommendations for sexually transmitted diseases (STDs). Low voluntary screening rate for sexually transmitted diseases (STDs) is major restrain for this market.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=169542
Global Sexually Transmitted Diseases (STDs) Drugs: Segmentation
The global sexually transmitted diseases (STDs) drug market has been segmented on the basis of disease type, therapy class, distribution channel, and region. On the bases of disease type, sexually transmitted diseases (STDs) drug market can be further segmented into chlamydia, gonorrhea, syphilis, human papillomavirus infection, HIV/AIDS and others. According to therapy class sexually transmitted diseases (STDs) drug market can be segmented into antibiotics, antiviral, vaccines and others. Antiviral drugs are used in the treatment of lethal viral infections caused by viruses like human immunodeficiency virus (HIV), hepatitis, influenza A and B viruses and herpes viruses. Vaccination has been promoted as a vital public health intervention across the globe for decades. According to the World Health Organization (WHO), vaccination has reduced the global burden of infectious disease to a great extent. In terms of distribution channel, the sexually transmitted diseases (STDs) drug market can be segmented into hospitals pharmacies, retail pharmacies, online pharmacies and others. In terms of revenue, the hospitals segment held a significant share of the sexually transmitted diseases (STDs) drug market in 2016.
Global Sexually Transmitted Diseases (STDs) Drugs: Regional Outlook
Geographically, the global sexually transmitted diseases drug market is segmented into five regions: North America, Europe, Asia Pacific, Latin America and Middle East & Africa. These regions have been further segmented by countries, disease type, and therapy class and distribution channel. North America dominated the market and is anticipated to gain more market share by the end of 2025. The competition matrix section included in the report is likely to assist the existing players to increase their market shares and new companies to establish their presence in the global sexually transmitted diseases (STDs) drug market.
Companies Mentioned in Report
The report also profiles major players in the market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Major companies competing in the global sexually transmitted diseases drug market, and profiled in the report include Pfizer INC, Hoffmann La Roche, Bayer Healthcare, Eli Lilly, Johnson & Johnson, Bristol-Myers Squibb Co. AbbVie, Inc., Gilead Sciences, GlaxoSmithKline Plc, and Merck & Co., Inc.
Sexually Transmitted Diseases (STDs) Drug Market is segmented as below:
Sexually Transmitted Diseases (STDs) Drug Market, by Disease Type
Chlamydia
Gonorrhea
Syphilis
Genital herpes
HPV
HIV/AIDS
Others
Sexually Transmitted Diseases (STDs) Drug Market, by Therapy Class
Antibiotics
Antiviral/Antiretrovirals
Vaccines
Others
Sexually Transmitted Diseases (STDs) Drug Market, by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Sexually Transmitted Diseases (STDs) Drug Market, by Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Table of Content
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Research Approach & Methodology
3. Executive Summary
4. Market Definition
4.1. Introduction
4.1.1. Disease Definition
4.1.2. Industry Evolution / Developments
4.2. Market Overview
4.3. Key Market Conferences
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities
4.4.4. Key Trends
4.5. Global STDs Drug Market Revenue (US$ Mn) Forecast, 2017–2025
4.5.1. Market Revenue Projections (US$ Mn)
4.7. Porter’s Five Force Analysis
4.8. Market Outlook
Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/sexually-transmitted-disease-std-diagnostic-market-global-industry-analysis-size-share-growth-trends-and-forecast-2012-2018-report.html/toc
5. Global STDs Drug Market Analysis, by Disease Type
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Market Size (US$ Mn) Forecast By Disease Type
5.3.1. Chlamydia
5.3.2. Gonorrhea
5.3.3. Syphilis
5.3.4. Genital herpes
5.3.5. HPV
5.3.6. HIV/AIDS
5.3.7. Others
5.4 Global STDs Drug Market Attractiveness Analysis, by Disease Type
6. Global STDs Drug Market Analysis and Forecast, By Therapy Class
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Size (US$ Mn) Forecast, By Therapy Class
6.3.1. Antibiotics
6.3.2. Antiviral/Antiretrovirals
6.3.3. Vaccines
6.3.4. Others
6.4. Market Attractiveness By Application
Continue...
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Global Sexually Transmitted Diseases (STDs) Drugs: Overview
Sexually transmitted diseases (STDs), also referred as venereal diseases are infections that can pass from person to person during sex. These diseases are caused mainly due to bacteria, viruses, and / or parasites. Sexually transmitted diseases (STDs) often go undiagnosed because these infections usually do not exhibit visual symptoms. Chlamydia is a common sexually transmitted disease. It is caused by bacteria called Chlamydia trachomatis. It can infect both men and women. Gonorrhea is caused due to bacterial infection (bacterium Neisseria gonorrhoeae) that can be passed from one person to another during sex. The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss of ability to fight against the organism that causes disease.
Global Sexually Transmitted Diseases (STDs) Drugs: Trends and Opportunities
The global market for sexually transmitted diseases (STDs) drug is expanding significantly, owing to increased chances of infection led by increase in the life expectancy of people across the globe. Rise in incidences of unprotected sex has led to an increase in the prevalence of sexually transmitted diseases. A driving factor for the sexually transmitted diseases (STDs) drug is rising initiatives by governments and multiple agencies drawn up guidelines or recommendations for sexually transmitted diseases (STDs). Low voluntary screening rate for sexually transmitted diseases (STDs) is major restrain for this market.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=169542
Global Sexually Transmitted Diseases (STDs) Drugs: Segmentation
The global sexually transmitted diseases (STDs) drug market has been segmented on the basis of disease type, therapy class, distribution channel, and region. On the bases of disease type, sexually transmitted diseases (STDs) drug market can be further segmented into chlamydia, gonorrhea, syphilis, human papillomavirus infection, HIV/AIDS and others. According to therapy class sexually transmitted diseases (STDs) drug market can be segmented into antibiotics, antiviral, vaccines and others. Antiviral drugs are used in the treatment of lethal viral infections caused by viruses like human immunodeficiency virus (HIV), hepatitis, influenza A and B viruses and herpes viruses. Vaccination has been promoted as a vital public health intervention across the globe for decades. According to the World Health Organization (WHO), vaccination has reduced the global burden of infectious disease to a great extent. In terms of distribution channel, the sexually transmitted diseases (STDs) drug market can be segmented into hospitals pharmacies, retail pharmacies, online pharmacies and others. In terms of revenue, the hospitals segment held a significant share of the sexually transmitted diseases (STDs) drug market in 2016.
Global Sexually Transmitted Diseases (STDs) Drugs: Regional Outlook
Geographically, the global sexually transmitted diseases drug market is segmented into five regions: North America, Europe, Asia Pacific, Latin America and Middle East & Africa. These regions have been further segmented by countries, disease type, and therapy class and distribution channel. North America dominated the market and is anticipated to gain more market share by the end of 2025. The competition matrix section included in the report is likely to assist the existing players to increase their market shares and new companies to establish their presence in the global sexually transmitted diseases (STDs) drug market.
Companies Mentioned in Report
The report also profiles major players in the market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Major companies competing in the global sexually transmitted diseases drug market, and profiled in the report include Pfizer INC, Hoffmann La Roche, Bayer Healthcare, Eli Lilly, Johnson & Johnson, Bristol-Myers Squibb Co. AbbVie, Inc., Gilead Sciences, GlaxoSmithKline Plc, and Merck & Co., Inc.
Sexually Transmitted Diseases (STDs) Drug Market is segmented as below:
Sexually Transmitted Diseases (STDs) Drug Market, by Disease Type
Chlamydia
Gonorrhea
Syphilis
Genital herpes
HPV
HIV/AIDS
Others
Sexually Transmitted Diseases (STDs) Drug Market, by Therapy Class
Antibiotics
Antiviral/Antiretrovirals
Vaccines
Others
Sexually Transmitted Diseases (STDs) Drug Market, by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Sexually Transmitted Diseases (STDs) Drug Market, by Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Table of Content
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Research Approach & Methodology
3. Executive Summary
4. Market Definition
4.1. Introduction
4.1.1. Disease Definition
4.1.2. Industry Evolution / Developments
4.2. Market Overview
4.3. Key Market Conferences
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities
4.4.4. Key Trends
4.5. Global STDs Drug Market Revenue (US$ Mn) Forecast, 2017–2025
4.5.1. Market Revenue Projections (US$ Mn)
4.7. Porter’s Five Force Analysis
4.8. Market Outlook
Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/sexually-transmitted-disease-std-diagnostic-market-global-industry-analysis-size-share-growth-trends-and-forecast-2012-2018-report.html/toc
5. Global STDs Drug Market Analysis, by Disease Type
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Market Size (US$ Mn) Forecast By Disease Type
5.3.1. Chlamydia
5.3.2. Gonorrhea
5.3.3. Syphilis
5.3.4. Genital herpes
5.3.5. HPV
5.3.6. HIV/AIDS
5.3.7. Others
5.4 Global STDs Drug Market Attractiveness Analysis, by Disease Type
6. Global STDs Drug Market Analysis and Forecast, By Therapy Class
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Size (US$ Mn) Forecast, By Therapy Class
6.3.1. Antibiotics
6.3.2. Antiviral/Antiretrovirals
6.3.3. Vaccines
6.3.4. Others
6.4. Market Attractiveness By Application
Continue...
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG